These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future. Zinner SH. Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995 [Abstract] [Full Text] [Related]
4. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children. Kovatch AL, Wald ER, Albo VC, Prin W, Orlando SJ, Wollman MR, Phebus CK, Shapiro ED. Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647 [Abstract] [Full Text] [Related]
9. Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient. Karp JE, Dick JD, Merz WG. Eur J Cancer Clin Oncol; 1988 Nov; 24 Suppl 1():S5-13. PubMed ID: 3127219 [Abstract] [Full Text] [Related]
14. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. Stein GE, Mummaw N, Goldstein EJ, Boyko EJ, Reller LB, Kurtz TO, Miller K, Cox CE. Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941 [Abstract] [Full Text] [Related]
15. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study. Cruciani M, Concia E, Navarra A, Perversi L, Bonetti F, Aricò M, Nespoli L. Infection; 1989 Oct; 17(2):65-9. PubMed ID: 2654019 [Abstract] [Full Text] [Related]